Literature DB >> 25246249

[Clinical significance of ITP-BAT bleeding grading system for patients with immune thrombocytopenia].

Ming'en Lyu1, Xiaofan Liu1, Rongfeng Fu1, Tiantian Sun1, Wenjie Liu1, Cuicui Lyu1, Renchi Yang1.   

Abstract

OBJECTIVE: To explore the clinical significance, reliability and responsiveness of ITPBAT bleeding grading system for patients with immune thrombocytopenia (ITP).
METHODS: One hundred and eighty-three patients with ITP were assessed by using of ITP-BAT bleeding grading system. Test-retest reliability, responsiveness of ITP-BAT bleeding grading system and association between bleeding grades and platelet counts, age, gender, disease stage were analyzed.
RESULTS: Bleeding degree of ITP patients and the platelet count were negatively correlated (r=- 0.744, P<0.01) and bleeding degree increased significantly with platelet counts below 20×10⁹/L (χ²=82.40,P<0.01). Mild bleeding rate in children was 68.5%, higher than that in adult(χ²=8.839,P<0.01), and severe bleeding rate in the elderly was 14.3%, higher than that in non-elderly(χ²=7.056,P<0.01). There were no significant differences in bleeding degree in patients with different gender and disease stage (χ²=4.922, P>0.05 and χ²=3.411, P>0.05). Bleeding grades before and after treatment had more significant difference(Z=-6.61, P<0.01). Scoring consistency of two doctors was 66.1% (κ=0.561), and scoring consistency of the same doctor was 94.7% (κ=0.874).
CONCLUSION: ITP-BAT bleeding grading system in China has good validity and responsiveness, closely related to clinical indicators. It is sensitive to the variation of the hemorrhage in patients. ITP-BAT could be used as a reference index of the treatment, and also be used as an observation index of curative effect.

Entities:  

Mesh:

Year:  2014        PMID: 25246249     DOI: 10.3760/cma.j.issn.0253-2727.2014.09.006

Source DB:  PubMed          Journal:  Zhonghua Xue Ye Xue Za Zhi        ISSN: 0253-2727


  1 in total

1.  [Comparative study between two bleeding grading systems of primary immune thrombocytopenia].

Authors:  S Xiao; Q Liu; M Hou
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2017-05-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.